Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Forus

Explore full profile

Automating prescription-to-approval workflows to help patients access medicine at no cost

New York City, United StatesFounded 2023Biotech & Life Sciences
Valuation $2.5–5B Last recorded · 2026
Revenue $50–100M Latest reported FY
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Forus and the history behind them.

About Forus

Forus is a healthcare technology innovator that functions as an AI-native operating system designed to bridge the gap between scientific breakthroughs and patient access. Originally founded as Tandem, the company focuses on removing the logistical and administrative obstacles that delay treatment, such as complex prior authorization processes and fragmented pharmacy routing. By providing a centralized platform that handles the end-to-end journey of a prescription, Forus aims to ensure that the "last mile" of healthcare is as efficient as the scientific research that precedes it.

Read full description

The company's target market includes the entire healthcare ecosystem: patients who need faster access to medicine, clinicians who are overwhelmed by administrative documentation, and biopharma companies looking to streamline drug launches. Unlike traditional healthcare software that adds costs to providers, Forus operates on a unique model where its automation tools are provided for free to healthcare professionals. Its primary value proposition lies in reclaiming clinical time for physicians and reducing the 10-to-15-year timeline typically required to bring and distribute new drugs to market.

Forus leverages advanced artificial intelligence to manage clinical workflows both during and after patient visits. Its technology includes automated prescription writing, real-time clinical decision support, and AI-driven coding assistants that integrate seamlessly with existing Electronic Health Record (EHR) systems. By automating these "administrative" steps, Forus transforms the clinical visit from a paperwork-heavy encounter into a patient-centered experience, using data-driven insights to accelerate medical approval and delivery at a global scale.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
New York City, United States
Employees
211
Open positions
7
Dealroom signal
92.7/100
Industry
Health
Sub-industry
Pharmaceutical, Health Platform
Sector
Biotech & Life Sciences, Health Care Information Technology, Medical Professionals, Medical & Healthcare, Core AI, Verified Unicorns and $1B Exits, Tech for Hospitals and Clinics, Tech for Medical Professionals
Technology
Artificial Intelligence
Business model
Marketplace & ecommerce
Client focus
b2b, b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing May 2026 $123M $1B Pear Ventures · Accel · Redpoint · General Catalyst ↗
SERIES AOther financing Jan 2024 $30M $120M BoxGroup · General Catalyst ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Forus website traffic

Latest recorded traffic for Forus is 160K monthly website visits, up 14.3% over the last three months. Forus's team declined 27% over the past year.

Latest monthly visits160K 3-month web change+14.3% 1-year team growth-27%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later5 investors entered at this stage

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States97.5%
🇬🇧 United Kingdom1%
🇫🇷 France0.5%
🇦🇺 Australia0.5%
🇮🇳 India0.5%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Forus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Forus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.